4
Changes in Ownership
COLLEGIUM PHARMACEUTICAL, INC Filed Acc 0001062993-25-014526
EVP & Chief Commercial Officer sold 4,861 shares at $38.03 ($184,881)
- EVP & Chief Commercial Officer acquired 4,861 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Dreyer Scott · EVP & Chief Commercial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-13 | Exercise or conversion : show line 1 in the form 10b5-1 | +4,861 | $21.34 | $103,734 | 108,474 | D |
| 2025-08-13 | Sale : show line 2 in the form 10b5-1 | −4,861 | $38.03 | $184,881 | 103,613 | D |
| Open-market sales · 4,861 sh · avg $38.03 · $184,881 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-08-13 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Purchase) | −4,861 | 16,389 | D |
Loading xslF345X05/form4.xml…